The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oncologists’ knowledge, clinical practices, barriers and facilitators of cardio-oncology guideline-concordant care.
 
Karine Ronan
Travel, Accommodations, Expenses - Pfizer
 
Coralea Kappel
No Relationships to Disclose
 
Eitan Amir
Honoraria - AstraZeneca; Gilead Sciences; Novartis (Inst); Pfizer; Seagen
Consulting or Advisory Role - AstraZeneca; Novartis
 
Jacqueline Savill
No Relationships to Disclose
 
Uri Bender
No Relationships to Disclose
 
Amal AlJuhani
No Relationships to Disclose
 
Jenna Smith-Turchyn
No Relationships to Disclose
 
Som Mukherjee
Speakers' Bureau - EMD Serono
Travel, Accommodations, Expenses - Amgen
 
Husam Abdel-Qadir
Employment - GlaxoSmithKline (I)
Honoraria - Bausch Health (I); Janssen (I); Novartis (I); ROC skincare (I); Sanofi (I); Valeant Pharmaceuticals International (I); Vivier (I)
Consulting or Advisory Role - Amgen Foundation (I); Bausch Health (I); Leo Pharma (I); Pfizer (I); Procter & Gamble (I)
Speakers' Bureau - Allergan (I); Biossance (I); Webber Naturals (I)
 
Vishal Kukreti
Honoraria - Amgen; Celgene; eusa pharmaceutical; Eusa Pharmaceuticals; Kirin Kyoto; Takeda
Consulting or Advisory Role - Amgen
(OPTIONAL) Uncompensated Relationships - American Society of Hemotology
 
Susan Dent
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Citrus Oncology; Gilead Sciences; Myocardial Solutions; Novartis; Pfizer
Research Funding - Novartis (Inst)
 
Michelle Nadler
Honoraria - Exact Sciences; Lilly; Novartis